Final results of a phase III randomized study of concurrent weekly cisplatin-RT versus RT alone in locoregionally advanced nasopharyngeal carcinoma (NPC).

被引：0
|
作者：
Chan, AT
Ngan, R
Teo, P
Leung, SF
Yiu, HY
Yeo, W
Mok, T
Cheung, FY
Kwan, W
Zee, B
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5523
引用
收藏
页码：493S / 493S
页数：1
相关论文
共 50 条
  • [41] Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A SecondaryAnalysis of a Prospective Phase III Clinical Trial
    Peng, Hao
    Chen, Lei
    Zhang, Yuan
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Fan
    Guo, Rui
    Liu, Li-Zhi
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    ONCOLOGIST, 2016, 21 (11): : 1369 - 1376
  • [42] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [43] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus chemoradiotherapy alone or radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Iocca, O.
    Ferraro, E.
    Gadaleta-Caldarola, G.
    Brandi, M.
    Filippelli, G.
    Infusino, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 69 - 69
  • [44] Induction chemotherapy plus radiotherapy alone versus cisplatin-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: An open-label, non-inferiority, randomized phase 3 trial.
    Chen, MingYuan
    Huang, Peiyu
    Chen, Xuyin
    Ding, Xi
    Ling, Guo
    Mo, Hao-Yuan
    Duan, Chongyang
    Ling, Li
    Zou, Xiong
    Liu, You-Ping
    You, Rui
    Xie, Yulong
    Cao, Jingyu
    Liu, Sihan
    Wang, Zimeng
    Yang, Qi
    Qiu, Fang
    Hua, Yijun
    Cao, Kajia
    Luo, Dong-Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Adjuvant capecitabine in locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized controlled phase III trial.
    Miao, Jingjing
    Wang, Lin
    Tan, Sze Huey
    Li, Jin-Gao
    Yi, Junlin
    Zhang, Ye
    Gong, Xiaochang
    Xiang Yanqun
    Chen, Qiu-Yan
    Chen, Mingyuan
    Lv, Xing
    Xia, Weixiong
    Tang, Lin-Quan
    Deng, Xiao-Wu
    Guo, Xiang
    Mai, Hai-Qiang
    Han, Fei
    Chua, Melvin Lee Kiang
    Zhao, Chong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Comparison of 3-weekly cisplatin versus 3-weekly carboplatin in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) receiving concurrent chemoradiotherapy (CCRT): A multicenter retrospective study
    Dechaphunkul, A.
    Danchaivijitr, P.
    Jiratrachu, R.
    Dechaphunkul, T.
    Sookthon, C.
    Jiarpinitnun, C.
    Paoin, C.
    Setakornnukul, J.
    Niyomnaitham, S.
    Suktitipat, B.
    Pattaranutaporn, P.
    Ngamphaiboon, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 384 - 384
  • [47] Induction Chemotherapy Plus Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis
    Li, Yang
    Tang, Lin-Quan
    Liu, Li-Ting
    Guo, Shan-Shan
    Liang, Yu-Jing
    Sun, Xue-Song
    Tang, Qing-Nan
    Bei, Jin-Xin
    Tan, Jing
    Chen, Shuai
    Ma, Jun
    Zhao, Chong
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1304 - 1315
  • [48] Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
    Chen, Yu-Pei
    Zhang, Wen-Na
    Tang, Ling-Long
    Mao, Yan-Ping
    Liu, Xu
    Chen, Lei
    Zhou, Guan-Qun
    Mai, Hai-Qiang
    Shao, Jian-Yong
    Jia, Wei-Hua
    Kang, Tie-Bang
    Zeng, Mu-Sheng
    Sun, Ying
    Ma, Jun
    BMC CANCER, 2015, 15
  • [49] Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial
    Zhang, Yuan
    Li, Wen-Fei
    Liu, Xu
    Chen, Lei
    Sun, Rui
    Sun, Ying
    Liu, Qing
    Ma, Jun
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 18 - 22
  • [50] A randomized study comparing neo-adjuvant chemotherapy and radiotherapy versus radiotherapy alone in locally advanced nasopharyngeal carcinoma (NPC)
    Al-Saleh, K
    Ragheb, A
    Ahmed, J
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 541 - 545
12345